Our data clearly demonstrate that an imetelstat concentration of 1 μM is sufficient to selectively target telomerase activity and induce telomere shortening in MPN mutant cells, as shown by a reduction of TL by 10% in PMF iPSC-derived CD34+ compared to HD cells. Here, CD34 is linked to myeloproliferative neoplasm.